Ledger.Open graph →
SEC Form D · filed July 20, 2016

Verona Pharma plc

Offering
$44.5M
Sold
$44.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LONDON, United Kingdom
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

David Ebsworth · LONDON, United KingdomDirectorKen Cunningham · Vancouver, British Columbia, CanadaDirectorAnders Ullman · LONDON, United KingdomDirectorJan-Anders Karlsson · LONDON, United KingdomExec · DirectorPatrick Humphrey · LONDON, United KingdomDirectorPeter Spargo · LONDON, United KingdomExecKenneth Newman · LONDON, United KingdomExecJan-Anders Karlsson · LONDON, United KingdomExec · DirectorDavid Ebsworth · LONDON, United KingdomDirectorPatrick Humphrey · LONDON, United KingdomDirectorPeter Spargo · LONDON, United KingdomExecKen Cunningham · Nashville, TNDirectorKenneth Newman · LONDON, United KingdomExecAnders Ullman · LONDON, United KingdomDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗